Kenya Retail Pharmacy Market Analysis Sample Report

Kenya Retail
Pharmacy Market
Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the Kenya Retail Pharmacy
Market and a forecast for its development in the medium and long term. It
provides a comprehensive overview of the market value, dynamics,
segmentation, main players, growth and demand drivers, challenges &
future outlook, etc. This is one of the most comprehensive reports about
the Kenya Retail Pharmacy Market, and offers unmatched value,
accuracy, and expert insights

3
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Retail Pharmacy Overview 12-24
1.1. Overview
1.2. Kenya Overview
1.3. Economic Overview: Kenya
1.4. Retail Pharmacy Market in Kenya
1.5. Pharmaceuticals Market in Kenya
1.6. Healthcare Scenario in Kenya
1.7. Health Insurance Coverage: Kenya
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 25-30
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Product
2.2.2. By Therapeutic Area
2.2.3. By Distribution Channel
3. Market Dynamics 31-35
3.1. Market Growth Drivers
3.1.1. Growing Population
3.1.2. Increasing Burden of Communicable Diseases
3.1.3. Rising Government Support
3.2. Market Restraints
3.2.1. Limited Healthcare Infrastructure
3.2.2. Regulatory Challenges

6
Table of Content
CONTENT PG. NO.
3.2.3. Financial Viability
4. Competitive Landscape 36-45
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Goodlife Pharmacy
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. Meds Pharmacy
4.2.2.1. Overview

7
Table of Content
CONTENT PG. NO.
4.2.3. Tuskys Pharmacy
4.2.3.1. Overview
4.2.4. Chandarana Pharmacy
4.2.4.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.5. The Nairobi Women's Hospital Pharmacy
4.2.5.1. Overview
4.2.6. Silvergate Pharmacies
4.2.6.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.7. Norkan Pharmacy
4.2.7.1. Overview
4.2.8. Haltons Pharmacy
4.2.8.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.9. Dawa Limited
4.2.9.1. Overview
4.2.10. Alpha Pharmacy
4.2.10.1. Overview

11
Table of Content
CONTENT PG. NO.
5. Reimbursement Scenario 46-53
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
6. Methodology & Scope 54-60

Kenya Retail Pharmacy Market Analysis
1. Retail Pharmacy Overview

13
Overview of Global Retail Pharmacy Trends
Retail Pharmacy Industry: Facts and Emerging Trends
▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
15% and 30%
Is regional pharmacies represented of
stores and prescription revenue
Respectively in US in 2021
138,000
Is on a per-store basis, retail chains
dispense annually about 50% more
than grocers, the next largest
prescription dispensers per retail
location in US in 2021
71% and 29%
Is the average sale of retail
pharmacies hospital pharmacies
respectively across the Asia
40%
of all pharmacies are still
independently owned in North America
>90%
Retail Pharmacies generate revenue
from prescription medications in North
America

14
1.1 Statistics at a Glance: The Burden of Retail Pharmacy in the World
(continued)
North America
~ Market Size of
$XX Bn
Europe
~Revenue to reach
$XX Bn by 2027
Asia
-Fastest CAGR
Kenya
~Market Size of
$XX Bn
Middle East
Market
~$XX Bn Market

15
1.2 Kenya Overview
54 Mn
Is the total
population of Kenya
in 2021
20.1 years
Is the median age
in Kenya
$$106.2 Bn
Gross domestic
product (GDP) of
Kenya in 2021
$6.5 Bn
Health expenditure in
Kenya in 2021
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest

16
1.3 Economic Overview: Kenya
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Kenya, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Kenya, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

17
1.4 Overview of Retail Pharmacy in Kenya
Highlights of Retail Pharmacy in Kenya
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Kenya
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
According to the Private Sector Innovation Programme for Health (PSP4H), 4,000 of the
country's 12,000 pharmacies are licensed by Kenya's Pharmacy and Poisons Board
(PPB) in Kenya
Kenya Pharmaceutical Association (KPA) is a professional group of regulated
pharmaceutical technologists with a membership of 7,500 of which 3,200 are community
pharmacists who either own or manage their stores
Kenya Pharmaceutical Association (KPA) is a professional group of regulated
pharmaceutical technologists with a membership of 7,500 of which 3,200 are community
pharmacists who either own or manage their stores
Kenya’s Pharmacy & Poisons Board (PPB) is actively involved in regulating and enhancing
the sector from a quality perspective, in 2011, for example, an estimated 20-25% of drugs
sold in the country were counterfeit

18
1.5 Pharmaceuticals in Kenya
XX XX XX XX XX XX XX XX XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Kenya Pharmaceuticals Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Pharmaceuticals market in Kenya, which includes the market size, current trends
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

19
1.6 Healthcare Scenario in Kenya
▪ Kenya's healthcare system is a mix of public and private providers. The Ministry of Health is responsible for policy formulation and overall
coordination of the sector
o Public healthcare services are offered through government hospitals, health centers, and dispensaries
o Private healthcare facilities are operated by non-governmental organizations (NGOs), faith-based organizations, and for-profit entities
▪ Kenya's healthcare system is a mix of public and private providers. The Ministry of Health is responsible for policy formulation and overall
coordination of the sector
▪ Universal Health Coverage (UHC): UHC program to provide affordable healthcare to all Kenyan citizens. The aim is to gradually expand
coverage and reduce the financial burden of healthcare
▪ Healthcare Workforce Development: Steps have been taken to address the shortage of healthcare professionals by training and hiring
more doctors, nurses, and other healthcare workers. Additionally, efforts have been made to deploy health workers to rural areas
Regulatory
Authority
▪ Pharmacy and Poisons Board (PPB) is the regulatory authority responsible for ensuring the quality, safety, and
efficacy of pharmaceutical products in Kenya.
Drug Registration ▪ PPB is responsible for the registration of pharmaceutical products in Kenya
Procurement and
Distribution
▪ Public procurement and distribution of pharmaceutical products in Kenya are primarily managed by the Kenya
Medical Supplies Authority (KEMSA)
Quality Control
▪ PPB conducts quality control inspections of pharmaceutical manufacturing facilities to ensure compliance with
Good Manufacturing Practices (GMP)
Pharmacovigilance
▪ In Kenya, the Pharmacovigilance Directorate under the Pharmacy and Poisons Board is responsible for
monitoring and reporting adverse drug reactions and ensuring the safety of pharmaceutical products
Key aspects related to pharmaceutical management in Kenya

20
1.7 Health Insurance Coverage: US
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

21
1.8 Budget of Kenya Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

22
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

23
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Walgreens Boots
Alliance Healthcare
Business was
acquired by
AmerisourceBergen
Acquisition
-
January
2021
▪ AmerisourceBergen and Walgreens Boots Alliance entered into a
strategic alliance
▪ Walgreens Boots Alliance Healthcare Business was acquired by
AmerisourceBergen, enabling it to increase its focus on growing
retail pharmacy business
Latest Deals In Kenya

24
1.9 Mergers and Acquisitions(continued)
Latest Deals In Kenya
Company Name Type
Amount /
Duration
Year Key Pointers
Merger -
Acquisition -
Illustrative

2. Market Size and Forecasting

26
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Kenya Retail Pharmacy Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Kenya Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Kenya Market Size (Bn $) 61 74 84 87 91 95 99 106
Illustrative

27
2.2 Snapshot of Retail Pharmacy Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Kenya Retail Pharmacy Market
By Product By Therapeutic Area By Distribution Channel
Prescription Drugs
Over-the-Counter
Medications
Vitamins &
Supplements
Medical
Equipment
Anti-Infective Online Pharmacy
Cardiovascular
Vitamins/Minerals/Nu
trients
Pain/Analgesics
Antibiotic
Dermatology
Neurology
Hospital Pharmacy
Community Pharmacy

28
Kenya Retail Pharmacy Market Share, By Product Type (2022)
Prescription
Drugs
Over-the-Counter
Medications
Vitamins &
Supplements
Medical Equipment
▪ Prescription drug market in Kenya is a
significant component of the overall
Retail Pharmacy treatment market
final report
2.2.1 Market Segmentation: By Product Type
Illustrative

29
Kenya Retail Pharmacy Market Share, By Therapeutic Area (2022)
Anti-Infective
Cardiovascular
Vitamins/Mineral
s/Nutrients
Pain/Analgesics
Antibiotic
Dermatology
Neurology
2.2.2 Market Segmentation: By Retail Pharmacy Type
▪ Anti-infective segment in Kenya is a
significant component of the overall
Retail Pharmacy market
▪ It has the maximum market share in
Kenya Retail Pharmacy Market with
approximately xx%
final report
Illustrative

30
Kenya Retail Pharmacy Market Share, By End User (2022)
Online Pharmacy
Hospital
Pharmacy
Community
Pharmacy
2.2.3 Market Segmentation: By End User
▪ Online Pharmacy have the maximum
market share in Kenya Retail
Pharmacy Market with approximately
xx%
final report
Illustrative

3. Market Dynamics

32
3.1 Market growth drivers
▪ Kenya has a rapidly growing population, which directly contributes to
increased demand for healthcare services, including pharmaceutical
products.
▪ As the population grows, the need for accessible retail pharmacies
expands to cater to the healthcare needs of the growing number of
people.
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.1 Current population of Kenya in 2023 is 55,100,586, a 1.99% increase from 2022. In 2022 was 54,027,487, a 1.93%
increase from 2021 and in 2021 was 53,005,614, a 1.96% increase from 2020
Population growth in Kenya

33
3.1 Market growth drivers
▪ Prevalence of diseases such as malaria, HIV/AIDS, tuberculosis,
diabetes, and cardiovascular diseases drives the demand for
pharmaceutical products
▪ Retail pharmacies play a crucial role in providing access to essential
medicines and managing chronic conditions, contributing to the growth of
the market
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.2 In Kenya 78.3% of total DALYs are constituted by years of live lost (YLL) due to premature mortality, with the
leading causes HIV/AIDS, lower respiratory infections, diarrheal diseases, tuberculosis, and malaria
Burden of communicable diseases in Kenya

34
3.1 Market growth drivers (continued)
3.1.2 Government of Kenya has made efforts to expand health insurance coverage, such as the National Health
Insurance Fund (NHIF) and private health insurance schemes
▪ With a growing number of individuals covered by health insurance, more people have access to healthcare services, including prescription
medicines
▪ This expanded access to healthcare services drives the demand for pharmaceutical products, benefiting the retail pharmacy market
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic
or subject matter of interest

35
3.2 Market restraints
3.2.1 Kenya's rural areas are often
characterized by remote and
geographically challenging terrain,
including mountainous regions and
vast distances
▪ Kenya faces challenges in terms
of limited healthcare
infrastructure, particularly in rural
and underserved areas
▪ Lack of adequate healthcare
facilities and trained personnel
can restrict the growth of the
retail pharmacy market, as it
becomes challenging to establish
and operate pharmacies in these
areas
3.2.2 Regulatory environment in Kenya
can pose challenges for retail
pharmacies due to the time-consuming
nature of compliance with regulatory
requirements
▪ The regulatory environment in
Kenya can present challenges
for retail pharmacies
▪ Compliance with regulatory
requirements, such as licensing,
registration, and quality
standards, can be demanding
and time-consuming
▪ Strict regulations and
bureaucratic processes can
impede the establishment and
growth of retail pharmacy
businesses
3.2.3 Limited purchasing power in
rural and underserved areas can pose
financial challenges for retail
pharmacies
▪ Establishing and sustaining a
pharmacy business requires a
certain level of financial viability,
which can be challenging in
areas with a small customer
base and low income levels
▪ Lack of financial viability makes it
less attractive for entrepreneurs
to invest in retail pharmacies in
these areas, further hindering
their growth
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

37
4.1 Major Market Share
▪ Kenya Retail Pharmacy Market is a highly
competitive space, with many companies
developing and marketing Retail Pharmacy
treatments
▪ Some of the top companies in Kenya Retail
Pharmacy Market based on revenue and
market share include
interest
Revenue of Major players in Kenya Retail Pharmacy Market ($ Mn)
XX
Company10
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Illustrative

38
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 Goodlife Pharmacy
3 Tuskys Pharmacy
5 The Nairobi Women's
Hospital Pharmacy
7 Norkan Pharmacy
9 Dawa Limited
2 Meds Pharmacy
4 Chandarana Pharmacy
6 Silvergate Pharmacies
8 Haltons Pharmacy
Alpha Pharmacy
10
Key Note:

39
4.2.1 Goodlife Pharmacy
Founded in: 2014
HQ: Nairobi, Kenya
Type: Private
Revenue: $84.4 Mn
Website: www.goodlife.co.ke/
▪ Goodlife Pharmacy is one of the largest retail pharmacy chains
in Kenya
▪ They operate multiple outlets across the country, offering a wide
range of pharmaceutical products, over-the-counter
medications, personal care products, and health services
▪ Company provides trusted pharmaceuticals to customers
across the population from convenient locations with a total
reach of over 2 Mn people with more than 120 branches in the
region
Solutions offered by Roche
➢ Amaan Khalfan- Chief Executive
Officer
➢ Justin Melvin- Chief Operations
Officer
➢ Kamau Munyoroku- Acting Chief
Finance Officer
➢ Yvonne Samantha Achieng-
Head of Marketing
Prescription Medications Over-the-Counter (OTC) Drugs
Health and Wellness Products Health Screenings
Family Planning and Sexual
Health
Home Delivery and Online
Ordering
Vaccinations Clinical Services
Medication Management Medical Equipment and Devices
Goodlife Pharmacy Services Recent Activity / Press Coverage
▪ June 2021, Goodlife Pharmacy Gives East African Moms Peace of Mind
with THINKMD’s Technology That “Thinks” Like a Doctor
▪ 2022, Goodlife Pharmacy is the largest healthcare provider and the #1
pharmacy chain in East Africa with over 70 stores in both Kenya and
Uganda
▪ They are accredited by the pharmaceutical board as providers of
genuine, quality products and have a broad range of products with a
portfolio ranging from: Skincare/dermatological products, supplements &
multivitamins, personal care and beauty products, as well all prescription
medication

40
4.2.1 Goodlife Pharmacy (continued)
Type
Amount /
Duration
Year Key Pointers
CFAO acquire 30%0f
stake of Goodlife
Pharmacy
Collaboration -
March,
2023
▪ CFAO Healthcare Acquires 30% Stake in Goodlife Pharmacies
from LeapFrog Investments as Part of Strategic Partnership
▪ Combination of Goodlife’s retail pharmacy network & brand, and
CFAO Healthcare’s existing wholesale distribution capabilities &
portfolio products will create strong synergies beneficial to the
business, the market, and the general public
Goodlife acquire
Greatness Pharmacy Acquisition -
February
2022
▪ International Finance Corporation (IFC) has backed Goodlife
Pharmacy for a stake in Nairobi-based Africa Greatness
Pharmacy sustaining its acquisition streak as it seeks control of
Kenya’s retail pharmaceutical space
▪ Nairobi-based Africa Greatness Pharmacy has a turnover of more
than Sh1 billion and assets worth over Sh81 Mn with an office in
Spring Valley.
Latest Deals - Mergers and Acquisitions

41
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.1 Goodlife Pharmacy (continued)
Revenues ($Bn), 2020-2030
▪ According to Goodlife Pharmacy’s 2022
financial report, the company had sales of
$XX Bn in 2022
▪ This is equivalent to approximately $XX Bn
USD, based on exchange rates at the end
of 2020
▪ Revenue generated by Goodlife Pharmacy
Health in 2022 reflects the company's
continued growth and success in the
healthcare industry
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

42
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Retail
Pharmacy
Recent Activity / Press Coverage
Illustrative

43
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

44
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

45
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario

47
5.1 Reimbursement Regulation in Kenya
In Kenya, pharmacy medication reimbursement is primarily facilitated through
health insurance schemes and government programs.
▪ National Hospital Insurance Fund (NHIF):
o NHIF is a government-run health insurance scheme in Kenya. Under
this program, eligible members contribute to the fund, and in return, they
receive access to healthcare services, including reimbursement for
pharmacy medications
o NHIF covers a wide range of prescription medications, and members
can obtain them at designated pharmacies upon presentation of a valid
NHIF card
▪ Private Health Insurance:
o Many private health insurance providers in Kenya offer coverage for
pharmacy medications as part of their health insurance plans
o The extent of coverage and reimbursement varies depending on the
specific insurance policy
o Individuals with private health insurance can usually claim
reimbursement for prescribed medications by submitting the necessary
documentation, such as invoices or receipts, to their insurance
company
Public and Private Health Insurance
Coverage in Kenya
National Hospital
Insurance Fund
(NHIF)
Private
Health
Insurance
Government
Health Programs
Employer-
sponsored
Health
Insurance
Out-of-Pocket
Payments
Health Insurance Coverage, 2022

48
5.1 Reimbursement Regulation (continued)
▪ Government Health Programs:
o Kenyan government implements various health programs that may include medication reimbursement for specific
populations or health conditions. For example, the government provides free antiretroviral therapy (ART) medications for
individuals living with HIV/AIDS through the National AIDS Control Council (NACC)
o Additionally, the government may subsidize or provide free medications for specific diseases or conditions as part of targeted
health interventions
▪ Employer-sponsored Health Insurance:
o Some employers in Kenya provide health insurance coverage for their employees, which may include reimbursement for
pharmacy medications
o Coverage and reimbursement terms are determined by the specific insurance plan offered by the employer
▪ Out-of-Pocket Payments:
o It's important to note that not all pharmacy medications are reimbursed, and individuals may need to pay out-of-pocket for
certain medications that are not covered by insurance schemes
o Additionally, some insurance plans may have limitations or exclusions for certain medications or require co-payments or
deductibles

49
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
 Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
 Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

50
5.2 Reimbursement Process for Retail Pharmacy
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

51
5.3 Reimbursement Process for Retail Pharmacy
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

52
5.4 Reimbursement Process - Medicare
Medicare
Population Covered
▪ 100% population is covered under this scheme
▪ Citizen’s contribute to this scheme which then earns an interest. There is Basic Healthcare Sum (BHS) cap which limits the maximum contribution to an
individuals Medicare account
Provider Restrictions/
Selection
Services can be claimed from Medicare-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, Retail Pharmacy centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicare and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicare account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicare account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicare up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for Retail Pharmacy up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal Retail Pharmacy up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative

53
5.5 Reimbursement Process - Medicaid
Medicaid
Population Covered
▪ 38% population is covered under this scheme
▪ Medicare covers individuals who are aged 65 and older, as well as those with certain disabilities or end-stage renal disease
Provider Restrictions/
Selection
Services can be claimed from Medicaid-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, Retail Pharmacy centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicaid and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicaid account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicaid account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicaid up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for Retail Pharmacy up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal Retail Pharmacy up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Kenya and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Kenya, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
MKenyaesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market research &
marketing professional with a
progressive experience of over 20 years
in Life Sciences, Pharma and Medical
Device sectors. With an in-depth
understanding of primary research, he
has conducted hundreds of interviews of
various stakeholders in pharma &
healthcare & completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Kenya, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
MKenyaesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Kenya Retail Pharmacy Market Analysis Sample Report

More Related Content

Similar to Kenya Retail Pharmacy Market Analysis Sample Report

More from Insights10

Recently uploaded

Kenya Retail Pharmacy Market Analysis Sample Report